S. 3257
Referred to CommitteeA bill to amend the Controlled Substances Act to lengthen the period of time during which certain controlled substances must be administered to a patient after being delivered by a pharmacy to the administering practitioner.
Latest Action
Read twice and referred to the Committee on the Judiciary.
11/18/2021 • Senate
Summary
This bill increases the number of days—from 14 to 60—within which a practitioner must administer certain narcotic drugs (e.g., buprenorphine) to a patient for maintenance or detoxification treatment (i.e., substance use disorder treatment) after receiving the drugs from a pharmacy. Additionally, the bill revises the process by which the Department of Justice may modify the number of days within which such drugs must be administered.
Introduced in Senate • 11/18/2021
Topics & Subjects
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (2)
Party Breakdown
Sponsor
Cosponsors (1)
Bill Journey
Originated in the Senate
Introduced
November 18, 2021
Read twice and referred to the Committee on the Judiciary.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law